A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Completed · Phase 1/Phase 2

Conditions studied: Open Angle Glaucoma, Ocular Hypertension

In brief

Slow release formulation of latanoprost is compared for safety and pressure-lowering efficacy with topically administration of commercially available latanoprost in patient with glaucoma and ocular hypertension

Key facts

Study ID

NCT02129673

Run by

ViSci Ltd.

People needed

77

Starts

2014-05-01

Expected to finish

2017-08-01

Last updated by the study team

2018-03-14

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18
• Open angle glaucoma or Ocular Hypertension

You may not qualify if…

• uncontrolled medical conditions
• wearing of contact lenses

Where it is running

• Speciality Eyecare Centre — Bellevue, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.